Anna Glantz, Sarah‐Jayne Reilly, Lisbet Benthin, Frank Lammert, Lars‐Åke Mattsson, Hanns‐Ulrich Marschall – 26 January 2008 – Intrahepatic cholestasis of pregnancy (ICP) is characterized by pruritus, elevated bile acids, and, specifically, elevated disulphated progesterone metabolites. We aimed to study changes in these parameters during treatment with dexamethasone or ursodeoxycholic acid (UDCA) in 40 out of 130 women included in the Swedish ICP intervention trial (26 randomized to placebo or UDCA, 14 randomized to dexamethasone).

Jun Li, Fawzia Bardag‐Gorce, Jennifer Dedes, Barbara Alan French, Fataneh Amidi, Joan Oliva, Samuel William French – 26 January 2008 – In previous studies, microarray analysis of livers from mice fed diethyl‐1,4‐dihydro‐2,4,6‐trimethyl‐3,5‐pyridine decarboxylate (DDC) for 10 weeks followed by 1 month of drug withdrawal (drug‐primed mice) and then 7 days of drug refeeding showed an increase in the expression of numerous genes referred to here as the molecular cellular memory. This memory predisposes the liver to Mallory Denk body formation in response to drug refeeding.

Bin Gao, Won‐Il Jeong, Zhigang Tian – 26 January 2008 – Blood circulating from the intestines to the liver is rich in bacterial products, environmental toxins, and food antigens. To effectively and quickly defend against potentially toxic agents without launching harmful immune responses, the liver relies on its strong innate immune system. This comprises enrichment of innate immune cells (such as macrophages, natural killer, natural killer T, and γδ T cells) and removal of waste molecules and immunologic elimination of microorganisms by liver endothelial cells and Kupffer cells.

Maria Serena Longhi, Francesca Meda, Pengyun Wang, Marianne Samyn, Giorgina Mieli‐Vergani, Diego Vergani, Yun Ma – 26 January 2008 – CD4+CD25+ regulatory T cells (T‐regs) are central to the maintenance of immune tolerance and represent an immune intervention candidate in autoimmune hepatitis (AIH), a condition characterized by impaired T‐reg number and function. We investigated whether T‐regs can be expanded from the existing CD4+CD25+ T cell pool and generated de novo from CD4+CD25− T cells in AIH patients and healthy controls.

Daniela Kroy, Christian Trautwein – 26 January 2008

26 January 2008

Kanji Yamaguchi, Liu Yang, Shannon McCall, Jiawen Huang, Xing Xian Yu, Sanjay K. Pandey, Sanjay Bhanot, Brett P. Monia, Yin‐Xiong Li, Anna Mae Diehl – 26 January 2008 – Retinyl ester (RE) stores decrease during hepatic stellate cell (HSC) activation and liver fibrosis. Although retinol esterification is mostly catalyzed by lecithin:retinol acyltransferase (LRAT), diacylglycerol acyltransferase (DGAT)1 also does this.

Gerben J. van der Bij, Steven J. Oosterling, Marijn Bögels, Farien Bhoelan, Donna M. Fluitsma, Robert H. J. Beelen, Sybren Meijer, Marjolein van Egmond – 26 January 2008 – Currently, an operation is the only curative option for patients with colorectal cancer. Unfortunately, many patients will develop liver metastases even after successful resection of the primary tumor. Removal of primary colorectal carcinoma may paradoxically increase the risk of metastases development, because accumulating evidence suggests that surgical trauma can stimulate tumor growth.

Rie Utoh, Chise Tateno, Chihiro Yamasaki, Nobuhiko Hiraga, Miho Kataoka, Takashi Shimada, Kazuaki Chayama, Katsutoshi Yoshizato – 26 January 2008 – We previously identified a small population of replicative hepatocytes in long‐term cultures of human adult parenchymal hepatocytes (PHs) at a frequency of 0.01%‐0.09%. These hepatocytes were able to grow continuously through serial subcultures as colony‐forming parenchymal hepatocytes (CFPHs).

Konrad L. Streetz, Regis Doyonnas, Dirk Grimm, D. Denison Jenkins, Sally Fuess, Scott Perryman, Joseph Lin, Christian Trautwein, Judith Shizuru, Helen Blau, Karl G. Sylvester, Mark A. Kay – 26 January 2008 – The lack of adequate donor organs is a major limitation to the successful widespread use of liver transplantation for numerous human hepatic diseases. A desirable alternative therapeutic option is hepatocyte transplantation (HT), but this approach is similarly restricted by a shortage of donor cells and by immunological barriers.